Dr. Harold Brem, MD

Dr. Brem practices at Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health.

Dr. Brem's NPI, 1669557625, was assigned on October 26, 2006. Dr. Brem graduated from McGill University Faculty of Medicine in 1987. Dr. Brem's New York license number on file is 200972NY.

Dr. Brem's primary practice is Newark Beth Israel Medical Center, at 201 Lyons Ave, Newark, NJ 07112 in Essex County. The practice phone is (973) 926-7000.

Dr. Brem's primary practice is Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Brem to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brem practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Brem's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Brem is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Brem's licenses on file in 2 states: New York and New Jersey.

CMS data shows 287 Medicare services from Dr. Brem across 7 procedure codes in 2024, for 67 Medicare patients. Medicare paid $24,160 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 67 Medicare patients who saw Dr. Brem in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 4.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brem's median patient age at 60, with 58% women.

In 2024, Dr. Brem wrote 84 Medicare Part D claims for 32 patients. 82% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $603 in total drug cost. In 2023, CMS named 76 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Brem for performance year 2024, reported through an alternative payment model (APM). Dr. Brem accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 93 procedures of removal of tissue by Dr. Brem, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 33 papers to Dr. Brem, published from 2008 to 2019. 2012 was the busiest year, with 2. The most frequent topics are Wound Healing, Debridement and Diabetic Foot. Dr. Brem has published most often in Adv Skin Wound Care. Dr. Brem's most frequent co-authors are Scott A. Gorenstein, MD, Michael Samuel Golinko, FAAP, FACS, MA, MD and Robert S. Kirsner, MD.

Dmand AI links Dr. Brem to 4 clinical trials. Conditions studied include Diabetic Foot, Foot Ulcer and Pressure Ulcer. Winthrop University Hospital sponsors the most, 4.

CMS Open Payments shows 23 general payments to Dr. Brem from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Organogenesis Inc. paid the most, $1,727.

Dr. Brem graduated from McGill University Faculty of Medicine in 1987. Dr. Brem is a member of ACS, ADA, AMA, American Professional Wound Care Association, Association for the Advancement of Wound Care and European Pressure Ulcer Advisory Panel.

Dr. Brem is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.